Biolife Solutions (BLFS) Assets (2010 - 2026)

Biolife Solutions (BLFS) has reported Assets for 17 consecutive years, with $447.5 million the latest figure, recorded in Q2 2026.

• On a quarterly basis, Assets rose 15.56% year-over-year to $447.5 million in Q2 2026; TTM through Jun 2026 was $447.5 million, a 15.56% increase from a year earlier, with the FY2025 full-year figure at $405.9 million, up 1.6% from the prior year.
• Assets was $447.5 million for Q2 2026 at Biolife Solutions, up from $400.9 million in the prior quarter.
• Over five years, Assets peaked at $544.3 million in Q1 2022 and troughed at $375.0 million in Q2 2024.
• A 5-year average of $424.6 million and a median of $408.5 million in 2023 frame the typical range for Assets.
• The widest YoY moves for Assets: up 126.76% in 2022, down 18.77% in 2022.
• Over 5 years, Assets stood at $450.2 million in 2022, then declined by 8.33% to $412.7 million in 2023, then retreated by 3.2% to $399.5 million in 2024, then increased by 1.6% to $405.9 million in 2025, then advanced by 10.25% to $447.5 million in 2026.
• The last three Assets figures came in at $447.5 million (Q2 2026), $400.9 million (Q1 2026), and $405.9 million (Q4 2025), per Business Quant data.